Apex Biotechnology Corp (1733.TW) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · Taiwan · ISIN TW0001733004

Price
29.55 TWD
Market cap
2.96 bn TWD
P/E (2025)
18.13
P/S (2025)
1.52
Dividend yield
4.40 %
Net margin
8.38 %
Return on equity (ROE)
8.72 %
Return on assets (ROA)
6.75 %

Apex Biotechnology Corp financials

Fiscal year20242025
Revenue1.85 bn TWD1.94 bn TWD
Gross profit521.34 m TWD538.74 m TWD
Operating income128.51 m TWD140.73 m TWD
EBIT156.77 m TWD140.73 m TWD
Net income128.00 m TWD163.04 m TWD
Diluted EPS – continuing operations1.27 TWD1.63 TWD

Full history since 2002, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Apex Biotechnology Corp

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. It offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing systems. The company also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.